Stellar Biotechnologies Inc. (SBOT)

1.75 -0.02 (-1.13%)

IEX Real-Time Price

July 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 1.77

Price Open 1.78

Volume: 116,543

Avg Volume: 1.76M

Market Cap: 8.96M

P/E Ratio -0.52

52 Wk Range 1.65-10.85



SBOT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-06-15
5.12M
40,986
0.03
0.80%

2018-05-31
4.72M
244,910
0.16
5.19%

2018-05-15
923,880
73,686
0.94
7.98%

2018-04-30
887,214
30,702
4.53
3.46%




SBOT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-07-03
Q2 2018
N/A
0.00 (0)
0.00
0.00

2018-02-07
Q1 2018
N/A
-0.14 (1)
-0.13
0.01

2017-12-01
Q4 2017
N/A
-0.14 (1)
-0.12
0.02

2017-08-09
Q3 2017
AMC
-0.12 (1)
-0.12
0.00

News

Your Daily Pharma Scoop: Exelixis Publishes Positive Data, Stellar Trial Succeeds, Kalytera's Pre-IND Meet (2018-07-07 16:06 SeekingAlpha)

Stocks in News: Results from late-stage study of Exelixis' Cabometyx in liver cancer published in NEJM Exelixis ( EXEL ) announced results from the Phase 3 clinical trial of Cabometyx (cabozantinib) in treatment-experienced patients with hepatocellular carcinoma (HCC). The resu…

 


Statistics

Shares Outstanding: 5.12M

Top 15 Institution Percent: 6.10

Price To Sales: 103.05

Price To Book: 1.91

Revenue: 43899

Gross Profit: -293160

Cash: 19.58M

Debt: N/A

Return On Assets: -60.54

Return On Equity: -64.65

Profit Margin: N/A

Price History

Beta: -0.26

50-day Moving Avg: 2.38

200-day Moving Avg: 5.50

YTD Change: -70.29

5-day Change: -4.84

1-month Change: 1.14

3-month Change: -67.16

6-month Change: -73.10

1-year Change: -81.41

Revenue Per Share: 0.00

Revenue Per Employee: 1568.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Stellar Biotechnologies Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.stellarbiotechnologies.com

Stellar Biotechnologies Inc is a biotechnology company engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH) protein.